FDA Inspection 953417 — Beijing Taiyang Pharmaceutical Industry Company Ltd
The FDA completed an inspection of Beijing Taiyang Pharmaceutical Industry Company Ltd on November 19, 2015 in Beijing. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- November 19, 2015
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Beijing (China)